Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies

Article Abstract:

Neutrophils from human C5aR knock-in mice, in which the mouse C5aR coding region is replaced with that of human C5aR is used to immunize wild-type mice and to generate high-affinity antagonist monoclonal antibodies (mAbs) to human C5aR. Results reveal that of ~40 mAbs generated to C5aR, all potent inhibitors recognized a small region of the second extracellular loop that seems to be critical for regulation of receptor activity.

Author: Mackay, Charles R., Mackay, Fabienne, Hyun Lee, Koentgen, Frank, Zahra, David, Padkjaer, Soren B., Whitfield, Peter L., Vogelzang, Alexis, Zwirner, Jorg, Newton, Rebecca, Trina So, Thatcher, Jenny, Quan, Annie
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
Inflammation, Inflammation mediators, Structure

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Rapid generation of specific antibodies by enhanced homologous recombination

Article Abstract:

The rapid generation of specific monoclonal antibodies using the chicken DT40 B-cell line undergoing gene conversion is reported. It is discovered that the gene conversion frequency at the immunoglobulin locus is increased by treating DT40 cells with a histone deacetylase inhibitor, trichostatin A, thereby generating diversity at the immunoglobulin locus in the majority of treated cells.

Author: Takeda, Shunichi, Shibata, Takehiko, Seo, Hidetaka, Ohta, Kunihiro, Masuoka, Mieko, Murofushi, Hiromu
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
B cells

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin

Article Abstract:

A generally applicable model of a dual-specific, tetravalent immunoglobulin G (IgG)-like molecule (dual-variable-domain Ig (DVD-Ig)) is developed, which is engineered from two monoclonal antibodies while preserving activities of parental antibodies. The studies of DVD-Ig protein in an animal disease model has shown that it can be used as therapeutics in human diseases.

Author: McCarthy, Donna, Chengbin Wu, Hua Ying, Grinnell, Christine, Bryant, Shaughn, Miller, Renee, Calbbers, Anca, Bose, Sahana, Rong-Rong Zhu, Santora, Ling, David-Taber, Rachel, Kunes, Yune, Fung, Emma, Schwartz, Annette, Sakorafas, Paul, Gu, Jijie, Tarcsa, Edit, Murtaza, Anwar, Ghayur, Tariq
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
Viral antibodies, Antibodies

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, United States, Monoclonal antibodies, Immunoglobulins
Similar abstracts:
  • Abstracts: Mimetic entry and bandwagon effect: the rise and decline of international equity venture in China. Organizational slack and firm performances during economic transitions: two studies from an emerging economy
  • Abstracts: Compliance to owner's manual warnings: influence of familiarity and the placement of a supplemental directive
  • Abstracts: Simulation based stress tests of banks' regulatory capital adequacy. Backtesting for risk - based regulatory capital
  • Abstracts: How rating agencies achieve rating stability. The importance and subtlety of credit rating migration. Rating the rating agencies: anticipating currency crisis or debt crisis?
  • Abstracts: Enhancing service personnel effectiveness through the use of behavioral repertoires. A marketing-relevant framework for understanding service worker productivity
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.